Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: The Wellcome Foundation Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom Trading as: GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex UB11 1BT
Zovirax Tablets 200 mg.
| Pharmaceutical Form |
|---|
|
Dispersible film-coated tablet. |
Aciclovir BP 200 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Aciclovir |
Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation. |
| List of Excipients |
|---|
|
Core: Microcrystalline cellulose Or Ethanol Or Absolute alcohol Film coat:* Colour concentrate Y-1-7000, White Purified water * Coating concentrate contains: Hypromellose |
PVC/PVdC/Aluminium/Paper child resistant foil blister packs.
Pack size: 25 tablets.
The Wellcome Foundation Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Trading as:
GlaxoSmithKline UK, Stockley Park West, Uxbridge, Middlesex UB11 1BT
PL 00003/0344
Date of first authorisation: 14 November 1994
Date of latest renewal: 07 January 2011
| Drug | Countries | |
|---|---|---|
| ZOVIRAX | Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
